Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
63.27
+0.72 (1.14%)
Nov 21, 2024, 2:52 PM EST - Market open
Disc Medicine Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
74
Market Cap
1.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIRON News
- 8 days ago - Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 13 days ago - Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc. - GlobeNewsWire
- 17 days ago - Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval - GlobeNewsWire
- 19 days ago - Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 27 days ago - Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week - GlobeNewsWire
- 5 weeks ago - Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week - GlobeNewsWire
- 2 months ago - Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer - GlobeNewsWire
- 5 months ago - Disc Medicine: Hematological Disorders Treatment Advances With DISC-0974 Progress - Seeking Alpha